抗心律失常药物是治疗的主要手段。
抗心律失常药物控制的节奏，您的心。
II I类抗心律失常药物(例如胺碘酮)是通过延长动作电位来发挥作用的。
Class III anti - arrhythmic drugs (such as amiodarone) act ia prolongation of the action potential.
IIi类抗心律失常药物(例如胺碘酮)是通过延长动作电位来发挥作用的。
Class III anti-arrhythmic drugs (such as amiodarone) act ia prolongation of the action potential.
肥厚心肌对于抗心律失常药物的致心律失常毒性非常敏感，容易发生尖端扭转型室速。
Hypertrophied myocardium is prone to proarrhythmic toxicity and development of the torsade DE points type of ventricular tachycardia.
目的探讨氨茶碱联合抗心律失常药物治疗伴有窦性心律过缓的心律失常的疗效与安全性。
Objective To study the effect and safety of aminophylline and anti-arrhythmias drugs in patients with arrhythmias with sinus bradycardia.
对于有室性心动过速及不服用抗心律失常药物的植入心律转复除颤器患者也需特别注意。
The same may also be true for patients with implantable cardioverter defibrillators who have a history of ventricular tachycardia and who are not taking antiarrhythmic medications.
在过去的25年里，没有新的抗心律失常药物出现，这是个遗憾，因为对此类药物需求很大。
As you know, for 25 years we have not had any new antiarrhythmic drugs and that was a pity because there was an unmet need.
目前肺静脉隔离射频消融治疗房颤用于治疗复发性有症状的或对抗心律失常药物不敏感的房颤患者。
At present, pulmonary vein isolation with catheter ablation is an effective treatment in patients with symptomatic atrial fibrillation refractory or intolerant to anti-arrhythmic medications.
此外，房颤患者可能出现医源性死亡，例如，抗心律失常药物导致的促心律失常作用或抗凝药物导致的出血。
But they can also die of iatrogenic conditions for example proarrhythmia effect from anti-arrhythmia drugs or hemorrhage from anticoagulants.
由于钙调蛋白激酶能影响各种钙敏感离子电流及导致心律失常，有可能是一种有效的抗心律失常药物作用靶位。
Since CaM kinase is uniquely positioned to affect Ca 2 + sensitive ionic currents and resultant arrhythmias, CaM kinase may also be an effective antiarrhythmic drug target.
目的：通过急性药物试验，研究抗心律失常药物对心室晚电位（VLP）的影响，为选用合适的抗心律失常药物。
Objective: In order to select suitable antiarrhythmic agents (AAA), the effects of AAA on ventricular late potentials (VLP) were studied by acute drug trial;
结论：急性药物试验安全可行，无明显毒副作用，可作为VLP阳性患者选择合适抗心律失常药物的初步筛选试验。
Conclusion: Acute drug trial is safe and feasible. The trial can be used as initial screening trial to select suitable AAA for VLP positive patIents.
比较消融术(导管和外科手术方法)与抗心律失常药物对非阵法性(持续性或长程持续性)房颤患者的疗效及安全性。
To determine the efficacy and safety of ablation (catheter and surgical) in people with non-paroxysmal (persistent or long-standing persistent) atrial fibrillation compared to antiarrhythmic drugs.
但是由于存在较高的心律失常复发率和潜在的致心律失常作用，传统抗心律失常药物的临床治疗效果并不能令人满意。
However, the therapeutic effects of traditional antiarrhythmic medicines are far from satisfactory, because of the high rate of arrhythmia recurrence and the potential proarrhythmia effect.
在肺静脉隔离组，88%的患者服用了抗心律失常药物，没有服用抗心律失常药的患者中的71%，在其后6个月没有发生房颤。
Eighty-eight per cent of patients receiving antiarrhythmic drugs in the PVI group, and 71% not receiving these agents, were free of atrial fibrillation at 6 months.
方法和结果—对于这两种治疗方法，我们在至少对一种抗心律失常药物耐药的陈发性房颤患者中进行了一个随机的多中心的对比研究。
Methods and Results— We conducted a randomized multicenter comparison of these 2 treatment strategies in patients with paroxysmal AF resistant to at least 1 antiarrhythmic drug.
而对心律失常发生机制及药物抗心律失常作用机制的研究，也都聚焦于对心肌细胞离子通道及跨膜离子流的研究。
The studies of the mechanisms of arrhythmogenesis and the action of antiarrhythmic drugs have already focused on the events of ionic channel currents in isolated single heart cells.
抗病毒、抗心律失常及抗高血压药物的研究是目前新药研究中的热门课题。
Studies on Antiviral, anti-arrhythmia and anti-hypertension drugs are a hot field in modem medicinal chemistry.
抗病毒、抗心律失常及抗高血压药物的研究是目前新药研究中的热门课题。
Studies on Antiviral, anti-arrhythmia and anti-hypertension drugs are a hot field in modem medicinal chemistry.
应用推荐